Mannheimer Swartling is advising Probi AB in connection with mandatory public cash offer by Symrise AG
Probi is a leading player in probiotic research and the development of efficient and well-documented probiotics. Probi’s customers are leading companies in the Functional Food and Consumer Healthcare segments. Total income for 2013 totaled SEK 103.6 million. Probi’s share is listed on NASDAQ OMX Stockholm, Small Cap.
Probi is being advised by Mannheimer Swartling with Ragnar Lindqvist and Lisa Fennhagen serving as legal counsel.